China’s ‘New Three New Items’ Reshape Global Trade Landscape
China’s manufacturing sector has unveiled a new generation of high-tech export powerhouses — robots, artificial intelligence solutions, and innovative drugs — that are driving an unprecedented surge in foreign trade. Dubbed the “New Three New Items” (新新三样), these future-oriented industries are building on the success of the previous “New Three” (electric vehicles, lithium batteries, and solar cells) and signaling a fundamental shift in the country’s export structure.
In the first half of 2026, China’s total foreign trade volume surpassed 25 trillion yuan ($3.4 trillion) for the first time in a half-year period, according to CCTV News. Exports grew 13.4% year-on-year to 14.73 trillion yuan, marking 11 consecutive quarters of export growth despite global trade protectionism and a complex external environment.
From ‘Made in China’ to ‘Intelligently Made in China’
The evolution of China’s export catalog tells a story of rapid industrial upgrading. The “Old Three” — mobile phones, computers, and home appliances — continue to play a stabilizing role, with home appliance exports alone reaching 3,609.6 billion yuan in H1 2026. But it is the emergence of the “New Three New Items” that has captured the attention of global markets.
“The fundamental reason for export growth is the precise alignment of ‘Made in China’ with global demand of all kinds,” said Wang Jun, Vice Minister of the Customs General Administration, as reported by Southern Metropolis Daily.
Lyu Daliang, spokesperson for the Customs General Administration, noted that intelligence is continuously empowering the iterative renewal of China’s home appliance industry. “The transformation from ‘Made in China’ to ‘Intelligently Made in China’ allows global consumers to increasingly experience the convenience and comfort brought by Chinese home appliances,” he said.
Robots: From Factory Floors to Operating Rooms
China’s robotics industry has achieved leapfrog development, with exports spanning industrial robots, cleaning robots, surgical robots, and intelligent biomimetic robots. In a landmark milestone, 2025 marked the first year China became a net exporter of industrial robots.
H1 2026 data reveals the scale of this transformation:
- Cleaning robots and intelligent biomimetic robots: 180.9 billion yuan in combined exports
- Industrial robots: 62.9 billion yuan, up 18.6%, exported to 141 countries and regions
- Surgical robots: 4.8 billion yuan, up 330%, with export markets expanding from 23 to 49 countries
A significant development in 2026 was the introduction of dedicated customs tariff codes for cleaning robots and intelligent biomimetic robots — giving these products their own international trade “identity cards” for the first time.
In Suzhou’s Wuzhong District, a concentrated supply chain ecosystem has emerged where the supply chain radius for cleaning robots has been shortened to within 10 kilometers. Wu Qi, a robot company manager in the district, described how innovation cycles have accelerated dramatically: “We’ve shortened the project cycle from 9 months to as fast as 6 months. From releasing one generation of products per year, we can now rapidly iterate to two core product generations per year.”
AI Computing Power: The New Engine of Export Growth
Perhaps the most striking development is the explosive growth in AI-related exports. AI computing power hardware imports and exports reached 5.13 trillion yuan in H1 2026, up 56.6% year-on-year. According to Gao Shiwang, spokesperson for the China Chamber of Commerce for Import and Export of Machinery and Electronic Products, “Products related to the AI computing power industrial chain contributed nearly 60% of the export increment of mechanical and electrical products. Memory chips alone contributed more than 30% of the export increment.”
This positions China as a critical supplier in the global AI infrastructure buildout, with the UN reporting that global goods trade growth is increasingly concentrated in AI-related fields.
Innovative Drugs: China’s Biotech Breakthrough
The third pillar of the “New Three New Items” is perhaps the most transformative. Chinese-developed innovative drugs are now being licensed to global pharmaceutical giants in a reversal of the traditional technology transfer model. In H1 2026, Chinese biotech firms completed 105 out-licensing deals, with upfront payments reaching $5 billion and total deal value approaching $100 billion.
The landmark deal of the year was SanSheng Pharma’s licensing of its PD-1/VEGF bispecific antibody SSGJ-707 to Pfizer, with a record $1.25 billion upfront payment, as reported by Time Weekly in July 2025. This reflects a broader trend: global pharmaceutical giants are increasingly turning to Chinese innovators to fill their pipeline gaps.
According to 36Kr, total Chinese innovative drug BD (business development) transactions in 2026 are on track to surpass $150 billion, as multinational corporations shift from buying single products to acquiring entire technology platforms.
Heatwave-Driven Demand and Trade Diversification
Beyond the high-tech narrative, short-term factors have also boosted Chinese exports. Extreme heatwaves across Europe, with temperatures exceeding 40°C in multiple countries, triggered a surge in demand for Chinese cooling appliances. “Cooling” home appliances — air conditioners, fans, and refrigerators — accounted for 1,079.1 billion yuan of total exports.
Xu Kaixuan, a Haier product manager for the European market, explained how Chinese manufacturers adapted: “We use more copper tubes, larger fans, and more precise energy-saving algorithms to achieve A+++ energy efficiency. Compared with ordinary air conditioners, in the same room and same time, it can save about 42% electricity.”
Meanwhile, China’s trade network continues to diversify. Trade with Belt and Road Initiative countries reached 12.97 trillion yuan, up 14.8%, while trade with neighboring countries grew 20.6%, Latin America 16.2%, and Africa 19.6%. New rail routes — including Wuhan-Copenhagen (opened January 2026) and Wuhan-Baku, Azerbaijan (opened March 2026) — are expanding connectivity, while Yantian Port added 10 new international shipping routes in H1 2026 alone.
What This Means for Global Trade
The emergence of the “New Three New Items” represents more than just a shift in China’s export mix. It signals that China’s industrial policy — particularly the “15th Five-Year Plan” emphasis on future industries and the 2026 Government Work Report’s call for “creating a new form of intelligent economy” — is yielding tangible results.
China is moving up the value chain from assembly and manufacturing to research, development, and innovation. The country that was once the world’s factory for low-cost goods is increasingly becoming a source of cutting-edge technology and pharmaceutical innovation.
However, questions remain. Can the rapid growth in robot and AI exports be sustained as global demand normalizes and competition intensifies? Will Chinese innovative drugs achieve commercial success in Western markets beyond the licensing deals? And how will ongoing trade tensions with the US and EU affect the trajectory of these new export categories?
For now, one thing is clear: the “New Three New Items” have established China not just as a manufacturing powerhouse, but as an emerging force in the industries that will define the 21st-century global economy.